Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in Chronic Kidney Disease
NCT01100203Phase 3Terminated
- Start
- Apr 2010
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in chronic kidney disease (CKD). Started Apr 2010; status: terminated.
02
Drugs
eplerenone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01100203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100203.